Theme: New Chemotherapeutic approaches for treatment of Cancer

Cancer Science Congress 2023

Cancer Science Congress 2023

Conference Series considers it a great honour to extend an invitation to everyone in the world to the 37th International Conference on Cancer Science & Therapy, which will be place in November 09-10, 2023 Stockholm, Sweden.

The 2023 Cancer Science Congress will feature numerous interactive scientific sessions as well as novel cancer diagnostic and therapeutic approaches. The goal of this effort is to bring together under one roof the various scientific and business communities working in this area to study every facet of oncology.

Importance & Scope:

The 2023 Cancer Science Congress will be the ideal venue for all oncologists, Hematologists, researchers, and students involved in this sector to share their expertise regarding oncology research. Understanding the fundamental biological processes that are changed to improve efficacy, precision, survival, and quality of life is the goal of this international event.

The Cancer Science Congress 2023 is the premier gathering of international experts, training institutions, manufacturing medical device companies, business entrepreneurs, medical colleges, researchers, academicians, physicians, postdocs, students, pharmacy industries, academic scientists, industry professionals, diagnostic laboratory professionals, and decision makers from around the world to share their knowledge, experience, and research innovations.

Why should you attend Cancer Science 2023?

  • Sessions with a purpose and accomplishments
  • To be inspired, meet academics and industry professionals.
  • Knowledge and global communication are all available in one location.
  • Functional peers will benefit from these sessions.
  • Increasing the amount of interactive knowledge
  • Poster presentations, paper presentations, and world-class displays are all available.
  • Possibilities for gaining a better knowledge
  • Meet new people with fresh skills.

CANCER SCIENCE CONGRESS 2023 provide Oncologists, radiologists, practitioners and educators a platform where they can put their education, training, and skills to valuable use and can discuss the most recent innovations, and practical challenges, encountered and solutions adopted in the field of Cancer science and Therapy.

Target Audience:

  • Automation and Robotics Lab Directors/Associates
  • Cancer genetics and epigenetics
  • Immunologists
  • Molecular Biology
  • Cancer Pharmacology
  • Biomedical Sciences
  • Automation doctorates
  • Control systems and Mechatronics expertise
  • Cardiothoracic Surgeon
  • Colon and rectal surgeon
  • Gynecologist
  • Radiologist
  • Gastrointestinal surgeon
  • Oncology surgeon
  • Associate professors
  • Nanotechnology Faculties and students
  • Medicine
  • Manufacturing Medical Devices Companies
  • Training Institutes
  • Business Entrepreneurs

Track 1: Cancer Epidemiology

Cancer epidemiology encompasses the examination of risk variables for the disease in order to identify potential patterns and causes. Finding the origin of cancer and identifying and developing better treatments are the goals of the study of cancer epidemiology. It can be used to pinpoint incidents that affect certain populations' cancer incidence either positively or negatively. Studies on cancer ethology, prevention, surveillance, and survivorship, as well as studies on survivorship, risk factors, analytical and molecular epidemiology, and the part played by behavioural factors in cancer ethology and prevention, are also included.

Track 2: Cancer Genetics

Cancer is an inherited disease caused by an increase in DNA mutations and epigenetic alterations that lead to unchecked cell division and the creation of tumours. Even if change can occur often in a group of people, they are still capable of adapting to the majority of changes. In this way, developing a tumour with a single transformation won't be possible. Typically, sickness is brought on by a variety of changes during the course of a person's lifespan. As a result of having multiple opportunities for change, this is why older people tend to acquire cancer. The depiction of characteristics relevant to cancer is controlled by oncogenomics. They are called protective cells because tumour suppressor genes, also known as oncogenes, regulate the cell cycle process.

Track 3: Cancer Metabolomics

Based on gene expression and DNA grouping, cancer genomics controls how the contrast between tumour cells and regular cells is portrayed. The goal of this inquiry is to better understand the fundamental hereditary characteristics of tumour progression, the alteration of the disease's genome, and the role of treatment in the cancer microenvironment. The study of the chemical traces a metabolite leaves behind during digestion is known as metabolomics. Examining the metabolite profile for sedative improvement in the event of the presence of tumour cells will be of the utmost importance. One of the many discoveries in disease metabolomics is the noninvasive validation of metabolic biomarkers from the bodily fluid of tumour patients.

Track 4: Cancer Types and Causes

The most prevalent cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukaemia, and pancreatic cancer.

It is well recognised that some lifestyle decisions raise your risk of developing cancer. Smoking, having more than one drink per day for women and up to two drinks per day for males, being fat, spending too much time in the sun, or getting frequent, painful sunburns, can all increase the risk of developing cancer.

Track 5: Cancer Biopsy

A biopsy is a diagnostic procedure typically performed by a specialist, interventional radiologist, or interventional cardiologist to remove test cells or tissues for analysis in order to determine whether a disease condition is present. The biopsy is typically divided into two categories: excisional biopsy, in which the affected tissues or cells are removed, and incisional biopsy, in which a sample is removed from the affected locality for study. When a disease is suspected, excisional biopsy will be the first attempt; if it is unsuccessful, incisional biopsy will be used to determine whether the tumour is benign or malignant.

Track 6: Proto-Oncogenes

A typical gene that can cause cancer when it undergoes a mutation and changes, becoming an oncogene. Proto-oncogenes may perform a wide range of tasks within the cell. There are several proto-oncogenes that send out signals that cause cell division. Programmed cell death is regulated by other proto-oncogenes (apoptosis).


Oncogenes, or faulty forms of proto-oncogenes, are capable of causing an uncontrolled division of a cell. Even in the absence of typical development signals like those provided by growth factors, this growth is nevertheless possible. One important aspect of oncogene activity is that even one mutated copy can cause uncontrolled proliferation.

Track 7: Metastasis

Cancer that spreads from one side of the body to another or to nodes in the body fluid system that don't appear to be a stream primarily affects the brain, liver, lungs, and bones. However, it resembles the first cancer cells, which are thought of as the next stage of the first cancer cells, despite the pathological process cancer cells not matching the characteristics of the cells wherever it had been detected. All pathological process cancers are regarded as advanced forms of the disease. Cancer metastasis is referred to as being directly connected to every alternative. The main reason why cancer is seen as a fatal illness is because of how quickly it may spread throughout the body. This metastasis happens via the blood

Track 8: Processed Food And Cancer Risk

A high intake of ultra-processed food may increase one's risk of colon cancer and overall mortality, according to few studies. They weren't the first to discover that link. There is growing evidence that eating processed food can lead to fatal diseases like cancer.

Track 9: Cancer Cell Biology

Cancerous cells are able to divide uncontrollably. Disease cells ignore dynamic indicators that are necessary for maintaining cell proliferation, apoptosis, and cell shedding. In a cancer cell, the majority of traits change into flaws. Malignant tumours are the cause of growth because they can invade nearby tissues or attack them. It is possible for certain growth cells from these tumours to break off and spread to other parts of the body via the lymphatic or plasma systems, creating a second tumour cell far from the original one. This process is known as metastasis. Growth cell science incorporates sub-atomic, biochemical, and cell-based techniques into cancer pathogenesis to increase the likelihood of developing the disease.

Track 10: Cancer Biomarkers

The compounds known as cancer biomarkers act as indicators of the presence of cancer in the body. The biomarker, which is often an atom released by the tumour or as a result of the tumor's proximity, is a processable sign of the body's natural state. The biomarkers are used to assess the risk for disease patients. The quantitative way to find the tumour cells is consistently provided by the cancer biomarkers, particularly those specifically associated to hereditary modifications or epigenetic modification. The most valuable feature of a biomarker is its ability to be used as a symptomatic tool to determine if a tumour is localised or has spread to other organs. The biomarkers can also influence the prognosis for cancer.

Track 11: Targeted Cancer Therapy

One of the finest methods for treating sickness is the targeted cancer treatment, which kills cancer cells by concentrating on and inhibiting the specific particles needed for tumour growth. Molecular medicine should be able to block this. It is preferable to conventional chemotherapy, which just inhibits the growth of wild tumours. A wide range of tools are used in the field of molecular medicine to characterise subatomic structure and its constituent parts, as well as to detect flaws in quality and produce subatomic impedances to remedy them. This can also be referred to as biotherapy because the vast majority of the atoms used for focusing on are biopharmaceuticals.

Track 12: Stem Cell Therapy

Stem cell therapy refers to the use of stem cells to treat a medical condition. Stem cells are undifferentiated cells that have the ability to differentiate into several types of cells or multiple copies of the same cell. In multicellular organisms, these stem cells predominate. There are two different types of stem cells: embryonic stem cells, which come from the inner cell mass of the blastocyst, and adult stem cells, which can come from a variety of organs in an adult. This adult cell collaborates with the progenitor cells to function as the body's repair system. Due to excessive doses during cancer therapies like chemotherapy or radiation therapy, stem cells are killed. In order to treat or maintain the stem cell level in cancer patients, stem cell transplants are typically performed. Numerous cancer case reports demonstrate the effectiveness of stem cell therapy in treating cancer. The recent developments in cancer stem cell therapy can be learned about during cancer conferences.

Track 13: Gene Therapy & Artificial DNA

A novel therapeutic approach called gene transfer involves inserting new genes into a malignant cell or the tissue around it in order to kill the cell or delay the spread of the cancer. A wide variety of genes and vectors are being employed in clinical trials with positive results because to the versatility of this therapy method.

Artificial DNA is a modern technique to target and destroy cancer cells. The procedure was successful in lab tests against human cervical cancer, breast cancer, and mouse malignant melanoma cells.

Track 14: Cancer Nanotechnology

Nanotechnology gives researchers the opportunity to monitor and regulate macromolecules continuously and during the most rapid stages of cancer growth. It paves the way for chemotherapies to particularly target cancer-causing cells and neoplasms, impacting in meticulous tumour removal, and enhancing the restorative efficacy of radiation-based and other modern treatment methods. Researchers are now able to detect sub-atomic changes even when they only occur at the level of single cells thanks to the rapid and unobtrusive location of tumor-related particles made possible by nanotechnology. Additionally, completely new and very effective medicinal medicines may be produced through nanotechnology.

Track 15: Cancer Management And Prevention

The primary goal of tumour prevention is to lessen the risk of developing cancer. There are several factors to take into account when fighting tumours, such as maintaining a healthy lifestyle, avoiding drugs that cause cancer and their relatives, and getting cancer-prevention vaccines. Depending on the stage of the disease, a variety of approaches to cancer management should be possible. The finest option initially is the growth medical procedure. There are many treatments available to cope with the growth besides medical operation. The immunotherapy that supports strengthening the secure framework to treat growth. A few people will also choose elective medicine.

Track 16: Tumor Virology, Immunology & Cellular Pathology

Oncogenes, tumour suppressors, oncogenic cofactors, disruption of innate and adaptive immune responses, latency, viral mimicry/piracy of cellular regulatory genes, genomic instability, and the function of non-coding RNAs in viral pathogenesis are all topics covered by tumour virology. The goal of this study is to advance vaccine techniques for the treatment of cancers associated with viral infections as well as viral vectors for human cancer gene therapy.

The most well-known application of cancer immunology is cancer immunotherapy, which makes use of the immune system as a cancer treatment. Cancer immunology is an interdisciplinary area of biology that focuses on understanding the role of the immune system in the development and progression of cancer.

The field of pathology known as cytopathology focuses on studying and diagnosing diseases at the cellular level. In 1928, George Nicolas Papanicolaou established the field. In contrast to histopathology, which examines complete tissues, cytopathology typically examines samples of free cells or fragments of tissue.

Track 17: Radiation Oncology

Radiation oncology is the practise of treating cancer with ionising radiation. Most often, radiation treatment and chemotherapy are combined to treat tumours. Additionally, it makes the burden of the tumours smaller. Radiation therapy side effects are divided into two groups: immediate and delayed adverse effects. Retching, digestive discomfort, edoema, infertility, and other symptoms are the immediate effects. Fibrosis, epilation, heart infections, and other late signs include. Sometimes patients will also be affected by radiation enteropathy. Hormonal imbalance may also result from radiation therapy.

Track 18: Cancer Vaccines

Cancer vaccinations often either treat pre-existing cancer or stop it from developing. Cancer cells, cell fragments, or pure antigens are used to make cancer vaccines. In order to make the vaccinations, a patient's own immune cells may occasionally be taken and subjected to these compounds in a laboratory.

Track 19: Oncology Nursing And Care

The practise of oncology nursing includes the responsibilities of being a direct career, an educator, a consultant, an administrator, and a researcher. All care delivery settings where patients with cancer or those at risk for the disease receive medical attention, instruction, and counselling for cancer prevention, screening, and detection fall under the scope of oncology and cancer nursing. It also includes symptom treatment, care to maintain as much normal functioning as possible, appropriate screenings and other prevention actions, and supporting measures at the end of life.

Market Analysis Report:

Cancer is a condition marked by the unbounded growth and spread of aberrant cells. Unbridled aberrant cell proliferation might beget death. One in seven deaths worldwide are caused by cancer. Compared to AIDS, TB, and malaria, cancer is the leading cause of mortality. When countries are distributed grounded on income, cardiovascular ails are the main cause of mortality in high- income nations, and cancer is the third-loftiest cause of death in low- and middle- income nations( following cardiovascular conditions and contagious and parasitic conditions).

Breast Cancer Diagnostic and Drug Technologies: Global Markets:

The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.

Biological Therapies for Cancer: Technologies and Global Markets:

The global cancer biologics market should reach $143.0 billion by 2026 from $77.5 billion in 2021 at a compound annual growth rate (CAGR) of 13.0% for the forecast period of 2021 to 2026.

Major Medical Universities:


  • Harvard University
  • University of Minnesota
  • Kings College London
  • Feinberg School of Medicine
  • Pittsburgh School of Medicine
  • Yale University
  • University of Oxford Stanford University
  • UNC School of Medicine
  • Karolinska University
  • Mayo Medical School
  • University of Cambridge
  • Emory University
  • John Hopkins University
  • University of Wisconsin

Major Associations:


  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Cancer Research Partnership (ICRP)
  • International Agency for Research on Cancer (IARC)
  • American Society of Pediatrics Hematology/Oncology
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • Australian Prostate Cancer Research
  • Cancer Society of New Zealand
  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • German Cancer Research Centre

The 36th International Conference on Cancer Science & Therapy is held on December 12-13, 2022 Stockholm, Sweden, Webinar. The Cancer Science Congress 2022 Conference attracted Gynecologist, Radiologist, Gastrointestinal surgeon, Oncology surgeon, researchers, doctors, students, and other healthcare professionals from all around the world. The topic of our conference was cutting-edge Cancer research. The organization behind CANCER SCIENCE CONGRESS 2022 was Conference series LLC Ltd.

The purpose of the Cancer Science Conference is to give scholars working on CANCER SCIENCE CONGRESS 2022 a forum for international collaboration. The opening ceremony of the Cancer Science Conference was followed by the distinguished guests, the keynote address, and plenary sessions by well-known speakers.

Let us meet again@ CANCER SCIENCE CONGRESS 2023

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 02-03, 2023
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View